Breakthrough in Clinical Trials Fast ER
Galaxy CCRO is developing the first bedside, blood-based stroke test designed to transform emergency stroke diagnosis. Using advanced lateral flow technology, this test enables healthcare providers to identify stroke faster, more accurately, and with greater confidence. By reducing the vast diagnostic grey area created by vague symptoms and uncertain time of onset, our solution directly addresses key factors that contribute to patient morbidity and mortality.
The FASTER System
What is It
The FASTER System is a rapid point-of-care (PoC) diagnostic platform that delivers critical stroke information in less than 15 minutes.
How It Works
Our proprietary technology is built on the patent-protected protein biomarker Glutathione-S-Transferase Pi (GSTP). With only a few drops of blood and a simple lateral flow device, clinicians can quickly measure GSTP levels and infer essential data about the patient’s condition, including stroke presence and estimated time of onset.
Clinical Impact
The FASTER System equips medical teams with reliable, near-patient insight precisely when it matters most, improving diagnostic confidence and enabling faster, more effective treatment decisions.
Connect With Our Team
Have questions or want to learn more about our innovation? Our team is ready to support your next step in advancing stroke care.